Page 1 of 25
This article has been retracted. Please see the Retraction Notice for more detail: https://​doi.​org/​10.​1186/​s13048-020-00747-z
The original article was published in Journal of Ovarian Research 2020 13:3
The original article was published in Journal of Ovarian Research 2023 16:186
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13048-022-01060-7.
The original article [1] contains errors in Fig. 3C, Results and Discussion.
The original article was published in Journal of Ovarian Research 2019 12:125
The original article was published in Journal of Ovarian Research 2023 16:81
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13048-019-0593-2.
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13048-020-00723-7.
The original article was published in Journal of Ovarian Research 2023 16:29
The original article was published in Journal of Ovarian Research 2021 14:76
The original article was published in Journal of Ovarian Research 2022 15:56
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13048-021-00785-1.
The original article was published in Journal of Ovarian Research 2020 13:113
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13048-020-00754-0.
The original article was published in Journal of Ovarian Research 2020 13:37
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13048-016-0266-3.
The cancer cell metastasis and the acquisition of chemotherapy resistance remain huge challenge for ovarian cancer treatment. Previously, N-myc downstream-regulated ... ) serves as a tumor suppressor for many cancers
The role of lncRNA miR503HG has been investigated in several types of cancer, but its functions in ovarian cancer (OC) is unclear. Analysis of TCGA...
The Retraction Note to this article has been published in Journal of Ovarian Research 2021 14:24
Hereditary breast and ovarian cancer (HBOC) syndrome has increased predisposition to breast and/or ovarian cancer, and 24% of families with HBOC...BRCA1/2.... Timely diagnosis and identification of mutation carri...
New treatment strategies are emerging to target DNA damage response pathways in ovarian cancer. Our group has previously shown that the ... response and has potent cytotoxic effects in ovarian cancer cells. Here,...
Recent evidence has suggested that the capability of cancer to grow, propagate and relapse after therapy ... the cell population within the tumor, called cancer stem cells. Therefore, this subpopulation of ... MU...
The original article was published in Journal of Ovarian Research 2014 7:89
The original article was published in Journal of Ovarian Research 2013 6:218
Abstract
The original article was published in Journal of Ovarian Research 2018 11:36
The original article was published in Journal of Ovarian Research 2014 7:226
The original article was published in Journal of Ovarian Research 2013 6:210
The original article was published in Journal of Ovarian Research 2014 7:84
Propofol is a kind of common intravenous anaesthetic agent that plays an anti-tumor role in a variety of cancers, including ovarian cancer. However, the working mechanism of Propofol in ovarian cancer needs furth...
Professional society guidelines recommend risk-reducing salpingo-oophorectomy (RRSO) for women with pathogenic variants (PVs) in ovarian cancer-risk genes. Personalization of that intervention is ... specific phe...
Previous studies have revealed that miRNAs participate in the pathogenesis of ovarian cancer; however, whether miR-600 is also ... investigated the role of miR-600 in ovarian cancer progression. Here, miR-600 exp...
Ovarian cancer is a major gynecological cancer that has poor prognosis associated mainly to ... diagnosis. Cisplatin is an FDA approved ovarian cancer therapy and even though the therapy is ... representing cispl...
Tumor-associated macrophages (TAMs) are classified into two major phenotypes, M1 and M2. M1 TAMs suppress cancer progression, while M2 TAMs promote it. ... role of TAMs in the development of ovarian cancer. Here,...
Lymph node metastasis (LNM) is a major factor contributing to the high mortality rate of ovarian cancer, making the treatment of this disease challenging ... , the molecular mechanism underlying LNM in ovarian cancer
Malignant ovarian disease is characterised by high rates of mortality due to high rates of recurrent chemoresistant disease. Anecdotal evidence indicates this may be due to chemoresistant properties of cancer ste...
Macrophages play an essential role in regulating ovarian cancer immune microenvironment. Studies have shown that m6A methylation could influence immune microenvironment in cancer. In this study, we investigated t...
To establish a prognostic risk profile for ovarian cancer (OC) patients based on cancer-associated fibroblasts (CAFs) and gain a...
Cervical cancer is one of the most common and important gynecological cancers, which has a global concern with an ... women in the world who suffer from cervical cancer are developing advanced stages of the disea...
The therapeutic effect of poly (ADP-ribose) polymerase inhibitors (PARPi) monotherapy compared with platinum-based chemotherapy, and the impact to subsequent platinum-based chemotherapy after PARPi resistance wer...
The purpose of this meta-analysis was to determine the strength of the association between gynecologic surgeries, tubal ligation and hysterectomy, and ovarian cancer.
MicroRNAs are a group of small non-coding RNAs that are involved in development and diseases such as cancer. Previously, we demonstrated that miR-335 ... XI alpha 1 (COL11A1)-mediated epithelial ovarian cancer (E...
Non-SMC condensin I complex subunit G (NCAPG), a member of the subunit of condensin complex, is significantly overexpressed in various cancers and involved in the pathogenesis of cancers. However, the roles of NC...
Epithelial ovarian cancer (EOC) is one of the most ... to predict the overall survival (OS) and cancer-specific survival (CSS) in elderly EOC...
Despite receiving first-line treatment, ovarian cancer patients continue to experience a high rate of recurrence; nearly all women with ovarian cancer develop chemoresistance and succumb to the disease. In this s...
Emerging evidence suggests that the capacity of a tumor to grow and propagate is dependent on a small subset of cells within a tumor, termed cancer stem cells. In fact, cancer cells, like stem cells, can prolifer...
Mucinous epithelial ovarian cancer (mEOC) is a relatively uncommon subtype of ovarian cancer with special prognostic features, but there is ... study aimed to develop a nomogram for the cancer-specific survival (...
Ovarian cancer is a common gynecological malignant disease in ... antisense RNA 1 (ZNF252P-AS1) in ovarian cancer.
Ovarian cancer is the third most prevalent cancer in Indian women. Relative frequency of High grade serous epithelial ovarian cancer (HGSOC) and its associated deaths are...
Studies have revealed the implications of cancer-associated fibroblasts (CAFs) in tumor progression, ... pathways by which CAFs affected chemoresistance in ovarian cancer.
To investigate the detailed roles and mechanisms of tumor-derived exosomes in progression and metastasis of ovarian cancer in vitro.
Chemo/radio-resistance is a major obstacle in treating advanced ovarian cancer. The efficacy of current treatments may be improved by increasing the sensitivity of cancer cells to chemo/radiation therapies. Curcu...
Ovarian cancer accounts for more deaths than any other female reproductive tract cancer. The major reasons for the high mortality ... , improved diagnostic and therapeutic options for ovarian cancer are a pressin...
Cancer is widely believed to result from chronic ... (MPV) are considered as inflammatory markers for cancer. We investigated the values of RDW, MPV, and cancer antigen 125 (CA125), alone or in combination, for d...
2022 Citation Impact
4.0 - 2-year Impact Factor
4.7 - 5-year Impact Factor
1.118 - SNIP (Source Normalized Impact per Paper)
0.965 - SJR (SCImago Journal Rank)
2023 Speed
10 days submission to first editorial decision for all manuscripts (Median)
138 days submission to accept (Median)
2023 Usage
1,114,260 downloads
475 Altmetric mentions
Editor-in-Chief Dr Ben Tsang has been recognised by the Canadian Parliament for significant contributions to science. Please join us in celebrating this amazing achievement.
Editor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement.
Read more here.